Daxx promotes DNA damage repair through homologous recombination and inhibits cGAS-STING signal activation, suggesting that Daxx impairs colon cancer chemotherapy by restricting the cGAS-STING signal activation to mediate antitumor immune responses. This evidence concerns the gene CGAS and malignant colon neoplasm.